TEVA hyaluronic acid - 10 syrg. 25 mg X 2,5 ml (joint agent)
What are TEVA hyaluronic acid injections 25 mg?
The utilization of hyaluronic acid injections within joint treatment has proven to be a valuable approach for addressing the discomfort associated with osteoarthritis and rheumatoid arthritis. One notable option in this regard is TEVA hyaluronic acid, available in syringes, which demonstrates effectiveness akin to Adant Dispo injections. By engaging in a course of injections directed into the joint cavity, the therapy facilitates the restoration of depleted intra-articular fluid, essential for optimal joint function. This restorative process contributes to enhanced joint mobility and a marked reduction in pain levels.
A particularly noteworthy outcome of this treatment approach is its potential to forestall or significantly delay the necessity for joint replacement surgery. This implication holds significance as it may extend the period before such interventions become imperative, possibly spanning several decades. It's important to note that the administration of TEVA injections does not typically result in swelling. In fact, patients can often resume their regular activities a mere 10 minutes post-treatment.
However, it is important to note that the this medication should be administered only by healthcare professionals. Prior to commencing treatment, a comprehensive examination supported by X-rays is recommended to assess the suitability of the therapy for the individual. It is further advised that the frequency of administration should not exceed once per week or twice per year, to maintain the balance of treatment effectiveness and safety.
Active principles: sodium hyaluronate
Amount: 10 syringes
Maker: Takeda Teva Pharma Co., Ltd., Nichi-Iko Pharmaceutical Co., Ltd., Meiji Seika Pharma Co., Ltd., Japan
- osteoarthritis of the knee,
- frozen shoulder,
- knee pain of rheumatoid arthritis.
How to use
Osteoarthritis of the knee and frozen shoulder: the medicine should be injected by a healthcare professional into a joint cavity of knee or a joint of shoulder once a week, five consecutive times.
Rheumatoid arthritis: the medicine should be injected by a healthcare professional into a joint cavity of knee once a week, five consecutive times.
The treatment duration with this medicine should be determined by your doctor depending on your symptoms or response to this medicine.
Contraindications: do not use for pregnant or breastfeeding women. Do not use for patients with liver disorder or a history of it, patients with skin disease on injection site.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.